Temple Bar Investment Trust's Fiscal Year is From January To December.
The item "Price-To-Sales-Ratio" stands at 5.61 as of 06/30/2025.
As of the end of Temple Bar Investment Trust's second quarter, the item "Price To Sales Ratio" stands at 5.61. This represents a decrease of -10.36 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 2.75 compared to the value the year prior.
The Serie's long term average value is -8.05. It's latest available value, on 06/30/2025, is 13.66 higher, compared to it's long term average value.
The Serie's change from it's minimum value, on 06/30/2022, to it's latest available value, on 06/30/2025, is +76.55 .
The Serie's change from it's maximum value, on 03/31/2023, to it's latest available value, on 06/30/2025, is -20.57 .
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Berkshire Hathaway Inc - Price To Sales Ratio | 1,088,030,244,864.00 |
![]() | Blackstone Group Inc - Price To Sales Ratio | 186,696,990,720.00 |
![]() | BlackRock Inc - Price To Sales Ratio | 166,346,604,544.00 |
![]() | KKR & Co LP - Price To Sales Ratio | 119,832,821,760.00 |
![]() | BioPharma Credit PLC - Price To Sales Ratio | 101,856,345,600.00 |